Cargando…

Severe COVID-19 in Patients with B Cell Alymphocytosis and Response to Convalescent Plasma Therapy

Detalles Bibliográficos
Autores principales:	London, Jonathan, Boutboul, David, Lacombe, Karine, Pirenne, France, Heym, Beate, Zeller, Valérie, Baudet, Antoine, Ouedrani, Amani, Bérezné, Alice
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2020
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678568/ https://www.ncbi.nlm.nih.gov/pubmed/33219491 http://dx.doi.org/10.1007/s10875-020-00904-5

Ejemplares similares

Convalescent plasma therapy for B-cell–depleted patients with protracted COVID-19
por: Hueso, Thomas, et al.
Publicado: (2020)

A look-back at convalescent plasma to treat COVID-19
por: Garraud, Olivier, et al.
Publicado: (2021)

L-66 Le plasma convalescent COVID-19 pour le traitement de la COVID-19
por: Tiberghien, Pierre, et al.
Publicado: (2022)

Inflammatory markers and auto-Abs to type I IFNs in COVID-19 convalescent plasma cohort study
por: Cognasse, Fabrice, et al.
Publicado: (2022)

Protocole d’usage thérapeutique du plasma de convalescent de COVID-19–Suivi
por: Fillet, Anne-Marie, et al.
Publicado: (2021)

Convalescent plasma improves overall survival in patients with B-cell lymphoid malignancy and COVID-19: a longitudinal cohort and propensity score analysis
por: Hueso, Thomas, et al.
Publicado: (2022)

Efficacy of convalescent plasma for the treatment of severe influenza
por: Xu, Zhiheng, et al.
Publicado: (2020)

Convalescent Plasma for the Treatment of Severe COVID-19
por: Franchini, Massimo, et al.
Publicado: (2021)

Arthroplasty after septic arthritis of the native hip and knee: retrospective analysis of 49 joints
por: Portier, Elodie, et al.
Publicado: (2022)

Treatment of Severe COVID-19 with Convalescent Plasma in the Bronx, NYC
por: Yoon, Hyun ah, et al.
Publicado: (2020)

Treatment of severe COVID-19 with convalescent plasma in Bronx, NYC
por: Yoon, Hyun ah, et al.
Publicado: (2021)

Convalescent Plasma for the Treatment of Severe COVID‐19 Infection in Cancer Patients
por: Tremblay, Douglas, et al.
Publicado: (2020)

Effectiveness of convalescent plasma therapy in severe COVID-19 patients
por: Duan, Kai, et al.
Publicado: (2020)

High-Dose Convalescent Plasma for Treatment of Severe COVID-19
por: De Santis, Gil C., et al.
Publicado: (2022)

High-Dose Convalescent Plasma for Treatment of Severe COVID-19
por: Focosi, Daniele, et al.
Publicado: (2022)

Efficacy of convalescent plasma therapy in severe COVID-19 patients
por: Akay Cizmecioglu, Hilal, et al.
Publicado: (2021)

Totally Implantable Venous-Access Device Infection Causing Hematogenous Prosthetic Joint Infection: A Retrospective Case Series
por: Medina, Fernanda, et al.
Publicado: (2018)

Gardnerella vaginalis, from the Vaginal Microbiota to Prosthetic Joint Infection
por: Thomas, Marion, et al.
Publicado: (2019)

Convalescent plasma from people vaccinated after COVID-19 infection
por: Jabal, Kamal Abu, et al.
Publicado: (2021)

The Quality of Anti-SARS-CoV-2 T Cell Responses Predicts the Neutralizing Antibody Titer in Convalescent Plasma Donors
por: Kroemer, Marie, et al.
Publicado: (2022)

Streptococcal and Staphylococcus aureus prosthetic joint infections: are they really different?
por: Kherabi, Yousra, et al.
Publicado: (2022)

Cutibacterium acnes Prosthetic Joint Infections: Is Rifampicin-Combination Therapy Beneficial?
por: Saltiel, Grégoire, et al.
Publicado: (2022)

Pseudomonas aeruginosa prosthetic joint-infection outcomes: Prospective, observational study on 43 patients
por: Prié, Héloïse, et al.
Publicado: (2022)

Earlier the better: convalescent plasma
por: Tobian, Aaron A.R., et al.
Publicado: (2020)

The resurgence of convalescent plasma therapy
por: The Lancet Haematology
Publicado: (2020)

COVID-19 convalescent plasma
por: Tobian, Aaron A. R., et al.
Publicado: (2022)

A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia
por: Simonovich, Ventura A., et al.
Publicado: (2020)

COVID-19 convalescent plasma composition and immunological effects in severe patients
por: Acosta-Ampudia, Yeny, et al.
Publicado: (2021)

High-Dose Convalescent Plasma for Treatment of Severe COVID-19 (response)
por: De Santis, Gil C., et al.
Publicado: (2022)

Successful Convalescent Plasma Therapy in a Child With Severe Coronavirus Disease
por: Das, Sudipta Sekhar, et al.
Publicado: (2020)

Convalescent plasma therapy for severe Covid-19 in patients with hematological malignancies
por: Jeyaraman, Preethi, et al.
Publicado: (2021)

Get rid of the bad first: Therapeutic plasma exchange with convalescent plasma for severe COVID-19
por: Kesici, Selman, et al.
Publicado: (2020)

A consideration of convalescent plasma and plasma derivatives in the care of Severely-ill patients with COVID-19
por: Lung, Thomas, et al.
Publicado: (2020)

Functional Antibodies in COVID-19 Convalescent Plasma
por: Herman, Jonathan D., et al.
Publicado: (2021)

Immunomodulation Effect of Convalescent Plasma Therapy in Severe – Critical COVID-19 Patients
por: Fitriah, Munawaroh, et al.
Publicado: (2023)

Convalescent plasma trial shows no benefit
por: Brown, Matthew
Publicado: (2020)

Convalescent plasma to treat COVID-19
por: Bloch, Evan M.
Publicado: (2020)

Convalescent plasma for patients with COVID-19
por: Zeng, Furong, et al.
Publicado: (2020)

Convalescent plasma for COVID-19 considerations
por: Adiwinata Pawitan, Jeanne
Publicado: (2021)

Serosurveys and convalescent plasma in COVID-19
por: Pérez-Cameo, Cristina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kfd5f20rejctb6i3tkus0enllb